As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
Thursday 4/1 Insider Buying Report: EWTX, RYTM
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
On Tuesday, Edgewise Therapeutics (EWTX)'s Director, Jonathan D.
Root, made a $250,000 buy of EWTX, purchasing 15,625 shares at a cost of $16.00 each.
So far Root is in the green, up about 115.3% on their purchase based on today's trading high of $34.45.
Edgewise Therapeutics is trading up about 3.2% on the day Thursday.
And also on Tuesday, CEO David P.
Meeker purchased $201,713 worth of Rhythm Pharmaceuticals (RYTM), purchasing 10,000 shares at a cost of $20.17 a piece.
Rhythm Pharmaceuticals is trading up about 8.2% on the day Thursday.
So far Meeker is in the green, up about 15.8% on their purchase based on today's trading high of $23.35.